XML 57 R51.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED ENTITIES AND ACQUISITIONS - Pro Forma Information (Details) - Entasis Therapeutics Holdings Inc - La Jolla Pharmaceutical Company - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Business Acquisition [Line Items]    
Revenue $ 357,880 $ 435,398
Net income 204,987 281,719
Net income attributable to Innoviva stockholders $ 214,390 $ 197,535